Is Therapeutic Drug Monitoring for Anti-tumour Necrosis Factor Agents in Adults With Inflammatory Bowel Disease Ready for Standard of Care? A Systematic Review and Meta-analysis. [electronic resource]
- Journal of Crohn's & colitis Sep 2020
- 1057-1065 p. digital
Drug Monitoring--methods Humans Inflammatory Bowel Diseases--diagnosis Pharmacovigilance Standard of Care Tumor Necrosis Factor Inhibitors--pharmacology